Giuseppe Guida
Turin, 10043, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter Cohort.
Journal: Journal of personalized medicine
Published: May 12, 2026
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.
Journal: Journal of asthma and allergy
Published: February 10, 2026
Traditional biomarkers and clinical hallmarks in the frame of epithelial driven airways inflammation.
Journal: Expert review of respiratory medicine
Published: December 13, 2025
Exhaled nitric oxide measurement in patients with connective tissue diseases associated with interstitial lung disease: a narrative review.
Journal: Medical gas research
Published: September 30, 2025
Maintenance of Effectiveness of Pirfenidone in Elderly Patients with Progressive Functional Impairment: A Real-World Retrospective Study in IPF.
Journal: Biomedicines
Published: September 29, 2025
Evidence of T2/T3 Endotype Overlap in Mild-to-Severe Asthma with Chronic Rhinosinusitis: A Pilot Study.
Journal: Annals of the American Thoracic Society
Published: September 17, 2025
Longitudinal observation of severe asthma comorbidities and oral corticosteroids use from SANI and ISAR registries.
Journal: The World Allergy Organization journal
Published: August 05, 2025
Fungal-Driven Airways Dis-Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities and Differences. An EAACI Task Force Report.
Journal: Allergy
Published: April 01, 2025
Dupilumab in the Treatment of Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma-A Multidisciplinary Monocentric Real-Life Study.
Journal: Biomedicines
Published: January 02, 2025
Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR).
Journal: The World Allergy Organization journal
Published: December 18, 2024
Vascular remodeling and TSLP/angiogenin overexpression in severe mixed asthma.
Journal: Respiratory research
Published: December 03, 2024
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab.
Journal: Journal of personalized medicine
Published: November 23, 2024
Last Updated: 09/26/2026